Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion type Assertion NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_head.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion description "[Risk analysis showed that NAT2 4/4 individuals (OR=1.95, 95% CI=1.05-3.60) and combined GSTM3 and NAT2 heterozygotes (OR=1.94, 95% CI=1.04-3.66) were at increased oral cancer risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_provenance.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion evidence source_evidence_literature NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_provenance.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion SIO_000772 16488179 NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_provenance.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion wasDerivedFrom befree-20140225 NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_provenance.
- NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_assertion wasGeneratedBy ECO_0000203 NP426563.RAGN9_Xhr-XO7BQv4cgs_OOAcF2DwDpMdpxA2NO8DCsBQ130_provenance.